Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Lowering the boom on lower-risk myelodysplastic syndromes

Mikkael A. Sekeres, Bhumika J. Patel

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 367–372.

https://doi.org/10.1182/hematology.2019000040

Published: 2019

Journal Articles

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Aaron T. Gerds

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 407–414.

https://doi.org/10.1182/hematology.2019000048

Published: 2019

Journal Articles

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Hanny Al-Samkari, Jean M. Connors

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 71–79.

https://doi.org/10.1182/hematology.2019000369

Published: 2019

Journal Articles

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

David C. Fajgenbaum

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 318–325.

https://doi.org/10.1182/asheducation-2018.1.318

Published: 2018

Journal Articles

Drug-associated thrombocytopenia

Tamam Bakchoul, Irene Marini

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 576–583.

https://doi.org/10.1182/asheducation-2018.1.576

Published: 2018

Journal Articles

Clinical and laboratory diagnosis of TTP: an integrated approach

Thita Chiasakul, Adam Cuker

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 530–538.

https://doi.org/10.1182/asheducation-2018.1.530

Published: 2018

Journal Articles

Assessing thrombocytopenia in the intensive care unit: the past, present, and future

Ryan Zarychanski, Donald S. Houston

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 660–666.

https://doi.org/10.1182/asheducation-2017.1.660

Published: 2017

Journal Articles

Current treatment algorithm for the management of lower-risk MDS

Aristoteles Giagounidis

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 453–459.

https://doi.org/10.1182/asheducation-2017.1.453

Published: 2017

Journal Articles

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Cindy E. Neunert

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 400–405.

https://doi.org/10.1182/asheducation-2017.1.400

Published: 2017

Journal Articles

Thrombocytopenia in pregnancy

Douglas B. Cines, Lisa D. Levine

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 144–151.

https://doi.org/10.1182/asheducation-2017.1.144

Published: 2017

Journal Articles

Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy

Marie Scully

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 651–659.

https://doi.org/10.1182/asheducation-2017.1.651

Published: 2017

Journal Articles

Hereditary thrombocytopenias: a growing list of disorders

Patrizia Noris, Alessandro Pecci

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 385–399.

https://doi.org/10.1182/asheducation-2017.1.385

Published: 2017

Journal Articles

Second-line therapies in immune thrombocytopenia

Rachael F. Grace, Cindy Neunert

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 698–706.

https://doi.org/10.1182/asheducation-2016.1.698

Published: 2016

Journal Articles

Congenital and acquired bleeding disorders in pregnancy

Terry B. Gernsheimer

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 232–235.

https://doi.org/10.1182/asheducation-2016.1.232

Published: 2016

Journal Articles

Platelets in liver and renal disease

Michele P. Lambert

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 251–255.

https://doi.org/10.1182/asheducation-2016.1.251

Published: 2016

Journal Articles

Heparin-induced thrombocytopenia: research and clinical updates

Oluwatoyosi Onwuemene, Gowthami M. Arepally

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 262–268.

https://doi.org/10.1182/asheducation-2016.1.262

Published: 2016

Journal Articles

Treatment of low-risk myelodysplastic syndromes

Valeria Santini

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 462–469.

https://doi.org/10.1182/asheducation-2016.1.462

Published: 2016

Journal Articles

First-line therapy for young patients with CLL

Nitin Jain, Susan O’Brien

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 146–148.

https://doi.org/10.1182/asheducation-2016.1.146

Published: 2016

Journal Articles

What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura

J. Evan Sadler

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 631–636.

https://doi.org/10.1182/asheducation-2015.1.631

Published: 2015

Journal Articles

Bleeding complications in immune thrombocytopenia

Donald M. Arnold

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 237–242.

https://doi.org/10.1182/asheducation-2015.1.237

Published: 2015

NARROW

Lowering the boom on lower-risk myelodysplastic syndromes

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancy

Novel insights and therapeutic approaches in idiopathic multicentric Castleman disease

Drug-associated thrombocytopenia

Clinical and laboratory diagnosis of TTP: an integrated approach

Assessing thrombocytopenia in the intensive care unit: the past, present, and future

Current treatment algorithm for the management of lower-risk MDS

Management of newly diagnosed immune thrombocytopenia: can we change outcomes?

Thrombocytopenia in pregnancy

Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy

Hereditary thrombocytopenias: a growing list of disorders

Second-line therapies in immune thrombocytopenia

Congenital and acquired bleeding disorders in pregnancy

Platelets in liver and renal disease

Heparin-induced thrombocytopenia: research and clinical updates

Treatment of low-risk myelodysplastic syndromes

First-line therapy for young patients with CLL

What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura

Bleeding complications in immune thrombocytopenia

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only